ReviewEuropean journal of microbiology & immunology2026
A bibliometric analysis of global research on plant-derived antimicrobials targeting Methicillin-resistant Staphylococcus aureus (2004-2024).
Review in European journal of microbiology & immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global surge in antimicrobial resistance (AMR) necessitates alternative therapeutic strategies, with plant-derived extracts emerging as promising candidates against methicillin-resistant Staphylococcus aureus (MRSA). Despite substantial experimental research, the global structure, thematic evolution, and collaborative landscape of this field remain uncharted. This study presents the first comprehensive bibliometric analysis of plant-based anti-MRSA research spanning two decades (2004-2024). A total of 1,468 publications across 535 peer-reviewed journals were analyzed using VOSviewer and Bibliometrix in R. Key findings include: (1) a shift from a Western-centric foundation to a polycentric, Global South-led collaboration network, despite Asia's dominance in output (China: 526; India: 427 publications); (2) a four-phase thematic evolution progressing from ethnobotanical screening to a frontier focused on nanoformulations and dual-target (antimicrobial/anti-inflammatory) strategies; and (3) identification of critical gaps between publication volume and translational progress. Scholarly output is highly collaborative (average 6.35 authors per document; 27.52% international collaborations) and exhibits strong citation visibility (28.18 citations/document). These insights provide an evidence-based framework to guide global collaboration, prioritize research funding, and accelerate the translation of plant-derived compounds into clinically viable anti-MRSA therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.